AAAAAA

   
Results: 1-10 |
Results: 10
CHARACTERIZATION OF A NEW BLM MUTATION ASSOCIATED WITH A TOPOISOMERASE II-ALPHA DEFECT IN A PATIENT WITH BLOOMS SYNDROME
Authors: FOUCAULT F VAURY C BARAKAT A THIBOUT D PLANCHON P JAULIN C PRAZ F AMORGUERET M
Citation: F. Foucault et al., CHARACTERIZATION OF A NEW BLM MUTATION ASSOCIATED WITH A TOPOISOMERASE II-ALPHA DEFECT IN A PATIENT WITH BLOOMS SYNDROME, Human molecular genetics, 6(9), 1997, pp. 1427-1434
COMPARATIVE GENOME HYBRIDIZATION
Authors: PLANCHON P
Citation: P. Planchon, COMPARATIVE GENOME HYBRIDIZATION, Biofutur, (165), 1997, pp. 10-10
ASPIRIN AND NSAIDS INDUCED APOPTOSIS IN SW480 CELLS ARE DIFFERENT THAN IN OTHER HUMAN COLON-CANCER CELL-LINES
Authors: BENAMOUZIG R JULLIAN E PLANCHON P CHAUSSADE S COUTURIER D RAUTUREAU J
Citation: R. Benamouzig et al., ASPIRIN AND NSAIDS INDUCED APOPTOSIS IN SW480 CELLS ARE DIFFERENT THAN IN OTHER HUMAN COLON-CANCER CELL-LINES, Gastroenterology, 112(4), 1997, pp. 537-537
RU-58668 - FURTHER IN-VITRO AND IN-VIVO PHARMACOLOGICAL DATA RELATED TO ITS ANTITUMORAL ACTIVITY
Authors: VANDEVELDE P NIQUE F PLANCHON P PREVOST G BREMAUD J HAMEAU MC MAGNIEN V PHILIBERT D TEUTSCH G
Citation: P. Vandevelde et al., RU-58668 - FURTHER IN-VITRO AND IN-VIVO PHARMACOLOGICAL DATA RELATED TO ITS ANTITUMORAL ACTIVITY, Journal of steroid biochemistry and molecular biology, 59(5-6), 1996, pp. 449-457
ALTERATION OF PROSTAGLANDIN-E RECEPTORS IN ADVANCED BREAST-TUMOR CELL-LINES
Authors: PLANCHON P VEBER N MAGNIEN V ISRAEL L STARZEC AB
Citation: P. Planchon et al., ALTERATION OF PROSTAGLANDIN-E RECEPTORS IN ADVANCED BREAST-TUMOR CELL-LINES, Molecular and cellular endocrinology, 111(2), 1995, pp. 219-223
EVIDENCE FOR SEPARATE MECHANISMS OF ANTIPROLIFERATIVE ACTION OF INDOMETHACIN AND PROSTAGLANDIN ON MCF-7 BREAST-CANCER CELLS
Authors: PLANCHON P VEBER N MAGNIEN V PREVOST G STARZEC AB ISRAEL L
Citation: P. Planchon et al., EVIDENCE FOR SEPARATE MECHANISMS OF ANTIPROLIFERATIVE ACTION OF INDOMETHACIN AND PROSTAGLANDIN ON MCF-7 BREAST-CANCER CELLS, Life sciences, 57(12), 1995, pp. 1233-1240
EVIDENCE FOR A GROWTH EFFECT OF EPIDERMAL GROWTH-FACTOR ON MDA-MB-231BREAST-CANCER CELLS
Authors: VEBER N PREVOST G PLANCHON P STARZEC A
Citation: N. Veber et al., EVIDENCE FOR A GROWTH EFFECT OF EPIDERMAL GROWTH-FACTOR ON MDA-MB-231BREAST-CANCER CELLS, European journal of cancer, 30A(9), 1994, pp. 1352-1359
SELECTION OF A HIGHLY TUMORIGENIC BREAST-CANCER CELL-LINE SENSITIVE TO ESTRADIOL TO EVIDENCE IN-VIVO THE TUMOR-INHIBITORY EFFECT OF BUTYRATE DERIVATIVE MONOBUT-3
Authors: PLANCHON P MAGNIEN V STARZEC A PREVOST G
Citation: P. Planchon et al., SELECTION OF A HIGHLY TUMORIGENIC BREAST-CANCER CELL-LINE SENSITIVE TO ESTRADIOL TO EVIDENCE IN-VIVO THE TUMOR-INHIBITORY EFFECT OF BUTYRATE DERIVATIVE MONOBUT-3, Life sciences, 55(12), 1994, pp. 951-959
PROLIFERATIVE RESPONSES OF EPITHELIAL-CELLS TO 8-BROMO-CYCLIC AMP ANDTO A PHORBOL ESTER CHANGE DURING BREAST PATHOGENESIS
Authors: STARZEC AB SPANAKIS E NEHME A SALLE V VEBER N MAINGUENE C PLANCHON P VALETTE A PREVOST G ISRAEL L
Citation: Ab. Starzec et al., PROLIFERATIVE RESPONSES OF EPITHELIAL-CELLS TO 8-BROMO-CYCLIC AMP ANDTO A PHORBOL ESTER CHANGE DURING BREAST PATHOGENESIS, Journal of cellular physiology, 161(1), 1994, pp. 31-38
DIFFERENTIAL ELIMINATION OF SYNTHETIC BUTYRIC TRIGLYCERIDES IN-VIVO -A PHARMACOKINETIC STUDY
Authors: PLANCHON P POUILLART P RONCO G VILLA P PIERI F
Citation: P. Planchon et al., DIFFERENTIAL ELIMINATION OF SYNTHETIC BUTYRIC TRIGLYCERIDES IN-VIVO -A PHARMACOKINETIC STUDY, Journal of pharmaceutical sciences, 82(10), 1993, pp. 1046-1048
Risultati: 1-10 |